![]() |
|
|


Unite des Maladies Metaboliques et Micronutrients, INRA Theix, 63122 Saint-Genes-Champanelle, France;
* UMR de Chimie Biologique, INRA-INAPG, Institut National Agronomique Paris-Grignon, 78850 Thiverval-Grignon, France;
Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan; and
** Institute for Preventive Medicine, Nutrition, and Cancer, Folkhalsan Research Center, and Division of Clinical Chemistry, University of Helsinki, PL 63, FIN-00014, Helsinki, Finland
1 To whom correspondence should be addressed. E-mail: scalbert{at}clermont.inra.fr.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: lignins lignans enterolactone phytoestrogens rats
Phytoestrogens are plant constituents with estrogenic properties that have been implicated in the prevention of breast and prostate cancers, osteoporosis or cardiovascular diseases (1,2). The most largely studied phytoestrogens are the soy isoflavones. Lignans form another class of phytoestrogens. Two main lignans, enterolactone (ENL)1 and enterodiol (END) (Fig. 1) were first detected in human urine and plasma and were called "mammalian lignans" (3,4). They bind weakly to estrogen receptors (5), have estrogenic effects in cultured cells (6,7) and can modulate the response to endogenous estrogens (8,9).
|
Animal experiments suggest that lignans may play a role in the prevention of cancers. Supplementation of the diet with plant lignans delays the progression of chemically induced mammary tumorigenesis in rats (2123). Inverse associations between the plasma concentration or urinary excretion of lignans and the risk of breast cancers were also observed (2428). The effect of mammalian lignans on prostate cancer was also examined. ENL and END inhibit the growth of human prostate cancer cell lines in vitro (29). However the dose used was much higher than that observed in vivo and no association was found between the excretion of ENL and prostate cancer in a case-control study (30).
Lignans may also influence bone metabolism and prevent osteoporosis. Continuous administration of SECO with the diet to nursing rat dams improved bone strength of young female offspring (31). In humans, the levels of ENL urinary excretion were lower in Korean postmenopausal women with osteoporosis compared with healthy women (32). However, the supplementation of postmenopausal women with 40 g of flaxseeds for 3 mo had no effect on biomarkers of bone metabolism (33).
Despite the potential importance of lignans in reducing disease risk, little is known concerning their dietary origin. Flaxseed was recognized as a rich source of lignans and continues to be their best dietary source (34,35). However, the low consumption of flaxseed in most human populations cannot explain the general occurrence of mammalian lignans in human tissues. High ENL and END levels in urine or plasma are generally associated with a high intake of dietary fiber and with the consumption of whole-grain food and fruit and vegetables (16,27,3640). It was suggested that the lignans contained in these food sources were the precursors of ENL and END. However, two studies in which rats or humans were fed whole-meal cereals or cereal bran showed that the content of SECO and MAT, the two main lignans identified in cereals, was too low by a factor of 525 to explain the levels of ENL and END excreted in urine (36,41). The recent identification of a number of lignans in rye (18) and other cereals still does not completely explain the urinary excretion of ENL and END. This suggests the existence of other precursors.
We propose here that lignins are major dietary precursors of mammalian lignans. Lignins are structurally related to lignans but differ from them by their polymeric nature and distribution in plants. They are cell-wall polymers made of phenylpropane units (Fig. 2) (42). The most common monomers in lignins are guaiacylpropane units (G); lignins are therefore structurally closely related to SECO and MAT (Fig. 1). Some lignins, like those in cereals, also contain syringylpropane (S) and p-hydroxyphenylpropane (H) units. They cannot be easily extracted by solvents unless they are chemically or physically degraded into smaller fragments. Lignins are found in vessels and secondary tissues of all higher plants. They are thus present in a large variety of foods, and are particularly abundant in cereal brans (43). In contrast, lignans are dimers of phenylpropane units, present in vacuoles and extractable by organic solvents (44). They are usually specific to a plant species such as SECO in flaxseeds.
|
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
The sample was applied in 2 x 200 µL of MeOH/CHCl3/H2O, 4:1:1, on a Lipidex 5000 column (0.5 x 5.0 cm in MeOH/CHCl3/H2O, 4:1:1). Lignans were eluted with 4 mL of MeOH/CHCl3/H2O, 4:1:1 (v/v/v). The fraction was dried completely under nitrogen, and dissolved in 0.5 mL MeOH. Further purification of the sample was carried out by chromatography on DEAE Sephadex in hydroxylated form and QAE Sephadex in its acetate form (Pharmacia Fine Chemicals, Uppsala, Sweden) (48). The sample was derivatized with 100 µL of pyridine/hexamethyldisilazane/trimethylchlorosilane (9:3:1) by incubating for 30 min at room temperature; it was transferred to a micro-vial and analyzed by GC-MS. Deuterated internal standards were not available for the new plant lignans; thus, quantification was done using deuterated MAT for analysis of LAR, PIN and SYR, and deuterated SECO and anhydrosecoisolariciresinol for analyses of ISOL and anhydroisolariciresinol, respectively.
Synthesis of dehydrogenation polymers. The labeled dehydrogenation polymer (DHP) was prepared by endwise polymerization of [9,9-2H2]-coniferyl alcohol (49). Aqueous solutions of coniferyl alcohol (2.0 g in 500 mL distilled water) and 0.05% hydrogen peroxide were simultaneously added dropwise using a micro-pump (flow rate: 20 mL/h) to a solution of horseradish peroxidase (5.0 mg in 500 mL in a 0.07 mol/L phosphate buffer, pH 6.5) for 24 h at room temperature. More peroxidase (5.0 mg) was then added to the reaction mixture and stirred for an additional 24 h. The resulting insoluble polymer was separated by centrifugation (15,000 x g, 30 min), dissolved in dichloroethane/ethanol 2:1 (v/v)(50 mL) and added dropwise to excess diethyl ether with vigorous stirring to eliminate the low-molecular-weight products such as monomers, dimers (= lignans) or trimers. The precipitate was recovered by centrifugation (15,000 x g, 30 min, 4°C) and washed five times with diethyl ether (5 x 40 mL). The elimination of lignans was confirmed by silica gel TLC with 1,2-dichloroethane/MeOH 20:1 (v/v) as eluant. The insoluble DHP was dried over phosphorus oxide in vacuo (yield, 1.3 g).
The DHP was characterized by thioacidolysis (50). The main monomeric products were 2-methoxy-4-(1,2,3-tris-ethylsulfanylpropyl)-phenol (I), 4-(1,3-bis-ethylsulfanyl-propyl)-2-methoxy-phenol (II) and 4-(3-ethylsulfanylpropenyl)-2-methoxy-phenol (III) with respective yields of 649, 263 and 127 µmol/g (Fig. 3). The high yield of (II) and (III) indicates a high content of ß-O-4linked coniferyl alcohol end-groups compared with natural lignins (50,51). Intermonomeric linkages were also quantified by thioacidolysis followed by Raney nickel desulfuration (52). The main dimers recovered were of the ß-5 type (IV and V) and ß-ß type (VI) (Fig. 3) (55.4 and 23.4%, respectively, of the total dimers) originating from phenylcoumaran and PIN structures, respectively.
|
100120 g were used. Rats were housed two per cage in a room maintained at 22°C with a 12-h light:dark cycle (light from 0800 to 2000 h) with access to food from 1600 to 2000 h. Rats were maintained and handled according to the recommendations of the Institutional Ethics Committee (Institut National de la Recherche Agronomique), according to decree no. 87848. In study 1, 48 rats were first adapted for 18 d to a semisynthetic basal diet. The basal diet consisted of casein (150 g/kg diet), wheat starch (755 g/kg diet), mineral mixture (35 g/kg diet), vitamin mixture (10 g/kg diet) and peanut oil (50 g/kg diet). The mineral mixture AIN-93M and vitamin mixture AIN-76A supplemented with choline were used (ICN Biochemicals, Aurora, OH) (53). After adaptation to the basal diet, rats were moved to metabolic cages, randomly assigned to 6 groups and different brans were added to the diets in place of an equivalent weight amount of starch. The six groups of rats were thus fed diets containing 15% rye bran, 10.7% extracted rye bran, 15% wheat bran, 10.2% extracted wheat bran, 3.2% lignin-enriched wheat bran or no bran for 5 d. On d 5, urine samples were collected for 24 h into plastic tubes containing ascorbic acid (Sigma Chemical, St. Louis, MO; 60 mg) and stored at -20°C until further analysis. All rats consumed their feed ad libitum throughout the experiment. Food intakes did not differ during the urine collection period and were (means ± SD) 19.0 ± 2.6, 20.1 ± 3.4, 21.2 ± 2.1, 19.6 ± 2.5, 18.8 ± 1.7, 19.8 ± 2.8 g dry matter/d in rats fed rye, extracted rye, wheat, extracted wheat, lignin-enriched wheat brans and controls diets, respectively.
In study 2, 12 rats were first fed the same 15% wheat bran diet as above for 14 d. They were moved to metabolic cages on d 10 and urine samples were collected for 24 h as described above on d 10 and 11. ENL was estimated in these urine samples and the three rats showing the highest level of lignan excretion were selected for feeding the DHP diet. This was done to maximize the chances of detecting labeled ENL when feeding low amounts of labeled DHP to a limited number of rats. On d 15, the three selected rats were fed the same wheat bran diet to which was added 0.2% labeled DHP for 3 d. Three other rats were fed the original 15% wheat bran diet as controls, and urine samples were collected for 24 h on these 3 d. All rats consumed their feed ad libitum throughout the experiment. Food intakes did not differ during the urine collection period and were (means ± SD) 21.8 ± 0.4 and 21.9 ± 2.5 g dry matter/d in rats fed the diet supplemented with DHP and the control diet, respectively.
Time-resolved fluoroimmunoassay (TR-FIA) for ENL. This immunoassay allows the specific estimation of ENL at a low concentration with very low cross-reaction for END (0.28%) and no interference from other compounds that have been investigated (5456). The assay was carried out as previously described (41). Briefly, urine samples were treated with ß-glucuronidase and sulfatase and ENL estimated using the DELFIA kit (Wallac Perkin Elmer, Turku, Finland) and a Victor 1420 multilabel counter.
Liquid chromatography electrospray ionization tandem MS (LC-ESI-MS/MS) analysis of lignans. Urine samples (175 µL) were diluted 10 times with 0.1 mol/L sodium acetate buffer pH 5. Genistein was added as an internal standard (3 µmol/L) and the solution acidified to pH 4.9 with 20 µL of 0.58 mol/L acetic acid and incubated at 37°C for 2 h in the presence of an Helix pomatia extract containing 1100 U ß-glucuronidase and 42 U sulfatase (G-0876, Sigma Chemical). After acidification to pH 2 with 2 µL of 6 mol/L HCl, the urine samples were extracted twice with ethyl acetate and centrifuged at 2400 x g for 10 min. The supernatant fluid was dried under nitrogen, redissolved in 500 µL of 25% aqueous MeOH and filtered (PTFE membrane, 0.45µm, Millipore, Bedford, MA). A 40-µL aliquot of the filtrate was then injected directly into the LC-ESI-MS/MS system.
LC-ESI-MS/MS analyses were performed on a Hewlett-Packard HPLC system with triple quadrupole MS-MS detection (API 2000, Applied Biosystem, Toronto, Canada). The column was an Hypersil BDS C18 (5 µm, 150 x 2.1 mm, Touzart & Matignon, Les Ulis, France) and the mobile phases consisted of 5% acetonitrile in 0.1% aqueous formic acid (solvent A) and 40% acetonitrile in 0.1% aqueous formic acid (solvent B). The following gradient was applied: 03 min, linear gradient from 0% B to 100% B, 315 min, 100% B. The flow rate was 0.2 mL/min. Detection was carried out by using electrospray ionization in negative mode at 450°C with a nebulizer pressure of 90 psi, a drying nitrogen gas flow of 11 L/min, a fragmentor voltage of 20 V and a capillary voltage of 4000 V. The MS data were collected in multiple reaction monitoring mode, monitoring the transition of parent and product ions specific to each compound with a dwell time of 500 ms. The selected parent and product ions for ENL, D2-ENL, END, D4-END and genistein internal standard were 297/253, 299/255, 301/253, 305/257 and 269/63, respectively.
Data analysis. All numerical values are expressed as means ± SD Significant differences in ENL excretion levels were determined by one-way ANOVA and Tukeys test in study 1 and by the unpaired two-tailed t test in study 2 (Instat, San Diego, CA). ENL excretion values were log-transformed before analysis. Differences with P < 0.05 were considered significant.
| RESULTS |
|---|
|
|
|---|
The bran-supplemented diets were fed to the rats for 5 d and ENL estimated in urine samples collected for 24 h by TR-FIA assay (Table 2). The ENL excretion did not differ significantly between rats fed untreated rye and wheat brans. When these brans were extracted with a Soxhlet, the excretion of lignans was significantly reduced to about one fourth the value in rats fed untreated brans but was still 56 times higher than that for control rats (P < 0.001). This shows that the nonextractable materials in brans still contain ENL precursors different from lignans.
|
Enterolactone formed from lignin dehydropolymers. Three rats were first fed a diet supplemented with 15% wheat bran for 14 d. A labeled lignin dehydrogenation polymer (DHP) was then added to this same diet (0.2%) for three more days and urine samples were collected for 24 h over these 3 d. The DHP group was compared with the control group fed the diet supplemented with wheat bran only. The excretion of both unlabeled and labeled-ENL was followed in urine by LC-ESI-MS/MS (Fig. 4). Feeding the labeled DHP greatly increased D2-ENL excretion compared with the control rats (19.9 vs. 0.9 nmol/d, P < 0.001 at d 3 of the DHP diet) (Fig. 5). Excretion levels of unlabeled ENL did not differ between the DHP-fed rats and control rats (the higher means for the DHP-fed rats is explained by the selection of the best lignan producers for feeding the labeled-DHP; see experimental section). The D2-ENL/nonlabeled ENL in the urine of the DHP-fed rats increased after d 12 of feeding the labeled DHP, reflecting the time needed for the DHP to be metabolized by the cecal microflora after ingestion. These results show unambiguously that lignins can be degraded into ENL, in a way similar to lignans.
|
|
| DISCUSSION |
|---|
|
|
|---|
In the present work, if we assume an average recovery yield of 32% in urine (58), SECO and MAT could account for no more than 20 and 14% of the ENL excreted in the urine of rats fed the diets supplemented with rye and wheat brans, respectively, and for 0 and <6%, respectively, when the same brans were previously extracted to remove the major part of the lignans. Other lignans such as PIN and LAR were also shown to be metabolized in high yields into ENL and END when incubated in vitro with a human fecal microflora (18). PIN and LAR were thus also estimated in the bran diets, in addition to SECO and MAT. If we assume the same recovery yield of 32% for the 4 lignans, they would then account for all (111%) and 49% of the ENL excreted after consumption of the rye and wheat bran diets, respectively, but for only 13 and 1%, respectively, when both brans were previously extracted with solvents. This clearly suggests the presence of other precursors.
The contribution of plant lignans to the formation of mammalian lignans could be somewhat underestimated because SYR, the major lignan in rye and wheat bran (3 times more abundant than SECO, MAT, PIN and LAR taken together), can also be converted to ENL and END, although in a yield which does not exceed 7% of those of the other four lignans (18).
Lignins are structurally related to lignans and may also be metabolized into mammalian lignans. Lignins were unequivocally detected by thioacidolysis in rye and wheat brans where they account for
5% of their weight (Table 1). Native lignins cannot be isolated without substantial degradation due to their insoluble and cross-linked nature (59). To examine whether lignins are effective precursors of mammalian lignans, a lignin-enriched wheat bran and a deuterated synthetic lignin (DHP) were prepared and fed to rats. When the lignin-enriched extractive-free wheat bran (310% lignin-enriched) was compared with the extractive-free wheat bran, ENL yields were similar when calculated on a lignin intake basis (78 and 58 nmol/g, respectively).
It is difficult to obtain pure lignins from complex plant materials and more particularly from materials such as brans, which have a relatively low lignin content compared with other lignocellulosic materials such as wood. For this reason, we prepared a synthetic lignin, free of any other contaminants. These synthetic lignins are prepared by oxidative polymerization of coniferyl alcohol and are called dehydropolymers (DHP). To differentiate ENL originating from the degradation of DHP from that originating from other constituents of the diet, a labeled DHP was prepared from [
,
-D2]-coniferyl alcohol. In the labeled DHP, the distal carbon of the propane side chain of most of the monomeric units carries two deuterium atoms in the place of hydrogen. The ENL that would result from the metabolism of the labeled lignins by the rat microflora would then carry two deuterium atoms.
When the labeled DHP was fed to rats, D2-ENL was specifically detected, showing that lignins can be metabolized into ENL in rats. The yield of D2-ENL was 655 nmol/g DHP (195 µg/g). This yield is
10 times higher than that calculated for bran lignins. These differences could be explained either by a limited accessibility to the substrate for bran lignins embedded in the cell wall or to structural differences between native bran lignins and synthetic lignins. To examine the first possibility, extractive-free wheat bran was thinly ground with a Retsch grinder (particle size < 0.5 mm) and fed to rats (not shown). The ENL urinary excretion was not affected by grinding. Therefore, a difference in substrate accessibility cannot be responsible for the difference in ENL yields between native and synthetic lignins.
The most likely explanation is a difference in the structure of the synthetic DHP compared with the bran native lignins. The precursors of mammalian lignans within the lignin are most likely the PIN and LAR structures (see dotted line circles, Fig. 2). The content of such structures in the DHP was determined by thioacidolysis followed by reduction with Raney nickel desulfuration (see experimental section). The PIN structures accounted for 23% of the total dimers recovered after such a chemical degradation. This value is much higher than that commonly observed for native lignins such as those present in cereal bran, and this difference most likely explains the high yield of ENL formation observed when the DHP is fed to the rats (60).
Lignins, because of their polymeric nature and of their embedding in the cell wall, are usually considered inert in the digestive tract. However, the present results show that they are metabolized by the gut microflora to form part of the ENL excreted in urine. Similarly, proanthocyanidins, natural phenolic polymers with antimicrobial properties, were also shown to be degraded into various phenolic acids by the gut microflora (6163). Another observation not previously noted is the absence of optical activity of ENL and END excreted in urine (64). A lignin origin for mammalian lignans is consistent with the absence of optical activity of lignins due to their biosynthesis through radical polymerization (65). This contrasts with the biosynthesis of plant lignans, which is stereospecific and leads to the formation of optically active lignans (66,67).
The respective contributions of lignins and plant lignans to the genesis of mammalian lignans can be evaluated from the comparison of the ENL excreted in urine after feeding whole brans or extractive-free brans (Table 2). Lignins account for 32 and 26% of the ENL excreted in the rats fed rye and wheat brans, respectively. Lignans present in brans would account for the remaining fraction.
The SECO and MAT intakes in Western populations were calculated using the SECO and MAT content in foods and beverages previously published (68). An intake of 1.53 µmol/d was determined for SECO and MAT in two Dutch and American cohorts (69,70), but this value could be 10 times higher if other lignans such as those estimated here in cereal brans were considered (70). The intake of these lignans explains in part the urinary excretion levels of mammalian lignans (0.527 µmol/d) in various populations (71). However, previously published lignan content values in food may be overestimated. Indeed, the analytical method used differs from the one used here by the mode of extraction of the lignans (48) and also gives positive values for SECO and other lignans when applied to a lignan-free lignin sample (S. Heinonen, H. Adlercreutz and A. Scalbert, unpublished results). Food composition tables for lignins do not exist. More data on lignan and lignin contents in foods will be required to determine their respective contributions to the mammalian lignan formation.
| FOOTNOTES |
|---|
Manuscript received 4 July 2003. Initial review completed 18 September 2003. Revision accepted 10 October 2003.
| LITERATURE CITED |
|---|
|
|
|---|
1. Adlercreutz, H. & Mazur, W. (1997) Phyto-oestrogens and Western diseases. Ann. Med. 29:95-120.[Medline]
2. Adlercreutz, H. (2002) Phyto-oestrogens and cancer. Lancet Oncol. 3:364-373.[Medline]
3. Setchell, K.D.R., Lawson, A. M., Mitchell, F. L., Adlercreutz, H., Kirk, D. N. & Axelson, M. (1980) Lignans in man and animal species. Nature (Lond.) 287:740-742.[Medline]
4. Axelson, M. & Setchell, K.D.R. (1980) Conjugation of lignans in human urine. FEBS Lett. 122:49-53.[Medline]
5. Adlercreutz, H., Mousavi, Y., Clark, J., Höckerstedt, K., Hämäläinen, E., Wähälä, K., Mäkelä, T. & Hase, T. (1992) Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Mol. Biol. 41:331-337.[Medline]
6. Jordan, V. C., Mittal, S., Gosden, B., Koch, R. & Lieberman, M. E. (1985) Structure-activity relationships of estrogens. Environ. Health Perspect. 61:97-110.[Medline]
7. Sathyamoorthy, N., Wang, T. T. & Phang, J. M. (1994) Stimulation of pS2 expression by diet-derived compounds. Cancer Res. 54:957-961.
8. Waters, A. P. & Knowler, J. T. (1982) Effect of a lignan (HPMF) on RNA synthesis in the rat uterus. J. Reprod. Fertil. 66:379-381.
9. Mousavi, Y. & Adlercreutz, H. (1992) Enterolactone and estradiol inhibit each others proliferative effect on MCF-7 breast cancer cells in culture. J. Steroid Biochem. Mol. Biol. 41:615-619.[Medline]
10. Borriello, S. P., Setchell, K.D.R., Axelson, M. & Lawson, A. M. (1985) Production and metabolism of lignans by the human fecal flora. J. Appl. Bacteriol. 58:37-43.[Medline]
11. Kilkkinen, A., Pietinen, P., Klaukka, T., Virtamo, J., Korhonen, P. & Adlercreutz, H. (2002) Use of oral antimicrobials decreases serum enterolactone concentration. Am. J. Epidemiol. 155:472-477.
12. Bowey, E., Adlercreutz, H. & Rowland, I. (2003) Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem. Toxicol. 41:631-636.[Medline]
13. Axelson, M., Sjövall, J., Gustafsson, B. E. & Setchell, K.D.R. (1982) Origin of lignans in mammals and identification of a precursor from plants. Nature (Lond.) 298:659-660.[Medline]
14. Rickard, S. E., Orcheson, L. J., Seidl, M. M., Luyengi, L., Fong, H.H.S. & Thompson, L. U. (1996) Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J. Nutr. 126:2012-2019.
15. Mazur, W. M., Duke, J. A., Wähälä, K., Rasku, S. & Adlercreutz, H. (1998) Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. Nutr. Biochem. 9:193-200.
16. Mazur, W. M., Uehara, M., Wähälä, K. & Adlercreutz, H. (2000) Phyto-oestrogen content of berries, and plasma concentrations and urinary excretion of enterolactone after a single strawberry-meal in human subjects. Br. J. Nutr. 83:381-387.[Medline]
17. Mazur, W. M., Wähälä, K., Rasku, S., Salakka, A., Hase, T. & Adlercreutz, H. (1998) Lignan and isoflavonoid concentrations in tea and coffee. Br. J. Nutr. 79:37-45.[Medline]
18. Heinonen, S., Nurmi, T., Liukkonen, K., Poutanen, K., Wähälä, K., Deyama, T., Nishibe, S. & Adlercreutz, H. (2001) In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J. Agric. Food Chem. 49:3178-3186.[Medline]
19. Saarinen, N. M., Warri, A., Makela, S. I., Eckerman, C., Reunanen, M., Ahotupa, M., Salmi, S. M., Franke, A. A., Kangas, L. & Santti, R. (2000) Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr. Cancer 36:207-216.[Medline]
20. Saarinen, N. M., Smeds, A., Makela, S. I., Ammala, J., Hakala, K., Pihlava, J. M., Ryhanen, E. L., Sjoholm, R. & Santti, R. (2002) Structural determinants of plant lignans for the formation of enterolactone in vivo. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 777:311-319.[Medline]
21. Thompson, L. U., Seidl, M. M., Rickard, S. E., Orcheson, L. J. & Fong, H. H. S. (1996) Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr. Cancer 26:159-165.[Medline]
22. Rickard, S. E., Yuan, Y. V., Chen, J. & Thompson, L. U. (1999) Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr. Cancer 35:50-57.[Medline]
23. Saarinen, N. M., Huovinen, R., Warri, A., Makela, S. I., Valentin-Blasini, L., Sjoholm, R., Ammala, J., Lehtila, R., Eckerman, C., Collan, Y. U. & Santti, R. S. (2002) Enterolactone inhibits the growth of 7, 12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat. Mol. Cancer Ther. 1:869-876.
24. McCann, S. E., Moysich, K. B., Freudenheim, J. L., Ambrosone, C. B. & Shields, P. G. (2002) The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J. Nutr. 132:3036-3041.
25. Hulten, K., Winkvist, A., Lenner, P., Johansson, R., Adlercreutz, H. & Hallmans, G. (2002) An incident case-referent study on plasma enterolactone and breast cancer risk. Eur. J. Nutr. 41:168-176.[Medline]
26. Dai, Q., Franke, A. A., Jin, F., Shu, X. O., Hebert, J. R., Custer, L. J., Cheng, J., Gao, Y. T. & Zheng, W. (2002) Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol. Biomark. Prev. 11:815-821.
27. Adlercreutz, H., Fotsis, T., Heikkinen, R., Dwyer, J. T., Woods, M., Goldin, B. R. & Gorbach, S. L. (1982) Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 2:1295-1299.[Medline]
28. Pietinen, P., Stumpf, K., Mannisto, S., Kataja, V., Uusitupa, M. & Adlercreutz, H. (2001) Serum enterolactone and risk of breast cancer: a case-control study in Eastern Finland. Cancer Epidemiol. Biomark. Prev. 10:339-344.
29. Lin, X., Switzer, B. R. & Demark-Wahnefried, W. (2001) Effect of mammalian lignans on the growth of prostate cancer cell lines. Anticancer Res. 21:3995-3999.[Medline]
30. Stattin, P., Adlercreutz, H., Tenkanen, L., Jellum, E., Lumme, S., Hallmans, G., Harvei, S., Teppo, L., Stumpf, K., Luostarinen, T., Lehtinen, M., Dillner, J. & Hakama, M. (2002) Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int. J. Cancer. 99:124-129.[Medline]
31. Ward, W. E., Yuan, Y. V., Cheung, A. M. & Thompson, L. U. (2001) Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Br. J. Nutr. 86:499-505.[Medline]
32. Kim, M. K., Chung, B. C., Yu, V. Y., Nam, J. H., Lee, H. C., Huh, K. B. & Lim, S. K. (2002) Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women. Clin. Endocrinol. 56:321-328.[Medline]
33. Lucas, E. A., Wild, R. D., Hammond, L. J., Khalil, D. A., Juma, S., Daggy, B. P., Stoecker, B. J. & Arjmandi, B. H. (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 87:1527-1532.
34. Thompson, L. U., Robb, P., Serraino, M. & Cheung, F. (1991) Mammalian lignan production from various foods. Nutr. Cancer 16:43-52.[Medline]
35. Nesbitt, P. D. & Thompson, L. U. (1997) Lignans in homemade and commercial products containing flaxseed. Nutr. Cancer 29:222-227.[Medline]
36. Juntunen, K. S., Mazur, W. M., Liukkonen, K. H., Uehara, M., Poutanen, K. S., Adlercreutz, H. C. & Mykkanen, H. M. (2000) Consumption of wholemeal rye bread increases serum concentrations and urinary excretion of enterolactone compared with consumption of white wheat bread in healthy Finnish men and women. Br. J. Nutr. 84:839-846.[Medline]
37. Kilkkinen, A., Stumpf, K., Pietinen, P., Valsta, L. M., Tapanainen, H. & Adlercreutz, H. (2001) Determinants of serum enterolactone concentration. Am. J. Clin. Nutr. 73:1094-1100.
38. Lampe, J. W., Gustafson, D. R., Hutchins, A. M., Martini, M. C., Li, S., Wähälä, K., Grandits, G. A., Potter, J. D. & Slavin, J. L. (1999) Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake. Cancer Epidemiol. Biomark. Prev. 8:699-707.
39. Jacobs, D. R., Jr, Pereira, M. A., Stumpf, K., Pins, J. J. & Adlercreutz, H. (2002) Whole grain food intake elevates serum enterolactone. Br. J. Nutr. 88:111-116.[Medline]
40. Kirkman, L. M., Lampe, J. W., Campbell, D. R., Martini, M. C. & Slavin, J. L. (1995) Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutr. Cancer 24:1-12.[Medline]
41. Nicolle, C., Manach, C., Morand, C., Mazur, W., Adlercreutz, H., Rémésy, C. & Scalbert, A. (2002) Mammalian lignan formation in rats fed a wheat bran diet. J. Agric. Food Chem. 50:6222-6226.[Medline]
42. Adler, A. (1977) Lignin chemistry, past, present and future. Wood Sci. Technol. 11:169-218.
43. Herranz, J., Vidal-Valverde, C. & Rojas-Hidalgo, E. (1981) Cellulose, hemicellulose and lignin content of raw and cooked Spanish vegetables. J. Food Sci. 46:1927-1933.
44. Ayres, D. C. Loike, J. D. eds. LignansChemical, Biological and Clinical Properties 1990 Cambridge University Press Cambridge, UK. .
45. Prosky, L., Asp, N.-G., Furda, I., Devries, J. W., Schweizer, T. F. & Harland, B. F. (1984) Determination of total dietary fiber in foods, food products, and total diets: interlaboratory study. J. Assoc. Off. Anal. Chem. 67:1044-1052.
46. Dence, C. W. (1992) The determination of lignin. Lin, S. Y. Dence, C. W. eds. Methods in Lignin Chemistry 1992:33-61 Springer Verlag Berlin, Germany. .
47. Lapierre, C., Pollet, B., Ralet, M.-C. & Saulnier, L. (2001) The phenolic fraction of maize bran: evidence for lignin-heteroxylan association. Phytochemistry 57:765-772.[Medline]
48. Mazur, W., Fotsis, T., Wähälä, K., Ojala, S., Salakka, A. & Adlercreutz, H. (1996) Isotope dilution gas chromatographic mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal. Biochem. 233:169-180.[Medline]
49. Nakatsubo, F. & Higuchi, T. (1975) Enzymic dehydrogenation of p-coumaryl alcohol. Holzforschung 26:64-68.
50. Lapierre, C., Monties, B. & Rolando, C. (1985) Thioacidolysis of ligninspreliminary study as compared to acidolysis. J. Wood Chem. Technol. 5:277-292.
51. Matsui, N., Fukushima, K., Kamada, K., Nishikawa, Y., Yasuda, S. & Terashima, N. (1994) On the behavior of monolignol glucosides in lignin biosynthesis. I. Synthesis of monolignol glucosides labeled with 3H at the hydroxymethyl group of side chain, and polymerization of the labeled monolignols in vitro. Holzforschung 48:215-221.
52. Terashima, N., Atalla, R. H., Ralph, S. A., Landucci, L. L., Lapierre, C. & Monties, B. (1996) New preparations of lignin polymer models under conditions that approximate cell wall lignification. II. Structural characterization of the models by thioacidolysis. Holzforschung 50:9-14.
53. Reeves, P. G., Nielsen, F. H. & Fahey, G. C., Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123:1939-1951.
54. Adlercreutz, H., Wang, G. J., Lapcik, O., Hampl, R., Wähälä, K., Makela, T., Lusa, K., Talme, M. & Mikola, H. (1998) Time-resolved fluoroimmunoassay for plasma enterolactone. Anal. Biochem. 265:208-215.[Medline]
55. Stumpf, K., Uehara, M., Nurmi, T. & Adlercreutz, H. (2000) Changes in the time-resolved fluoroimmunoassay of plasma enterolactone. Anal. Biochem. 284:153-157.[Medline]
56. Uehara, M., Lapcik, O., Hampl, R., Al-Maharik, N., Makela, T., Wähälä, K., Mikola, H. & Adlercreutz, H. (2000) Rapid analysis of phytoestrogens in human urine by time-resolved fluoroimmunoassay. J. Steroid Biochem. Mol. Biol. 72:273-282.[Medline]
57. Kang, M. H., Naito, M., Sakai, K., Uchida, K. & Osawa, T. (2000) Mode of action of sesame lignans in protecting low-density lipoprotein against oxidative damage in vitro. Life Sci. 66:161-171.[Medline]
58. Rickard, S. E. & Thompson, L. U. (1998) Chronic exposure to secoisolariciresinol diglycoside alters lignan disposition in rats. J. Nutr. 128:615-623.
59. Anterola, A. M. & Lewis, N. G. (2002) Trends in lignin modification: a comprehensive analysis of the effects of genetic manipulations/mutations on lignification and vascular integrity. Phytochemistry 61:221-294.[Medline]
60. Lapierre, C. (1993) Applications of new methods for the investigation of lignin structure. Jung, H. G. Buxton, D. R. Hatfield, R. D. Ralph, J. eds. Forage Cell Wall Structure and Digestibility 1993:133-163 American Society of Agronomy Madison, WI. .
61. Déprez, S., Brézillon, C., Rabot, S., Philippe, C., Mila, I., Lapierre, C. & Scalbert, A. (2000) Polymeric proanthocyanidins are catabolized by a human colonic microflora into low-molecular-weight phenolic acids. J. Nutr. 130:2733-2738.
62. Rios, L. Y., Gonthier, M.-P., Rémésy, C., Mila, I., Lapierre, C., Lazarus, S. A., Williamson, G. & Scalbert, A. (2002) Chocolate intake increases the urinary excretion of polyphenol-derived phenolic acids in healthy human volunteers. Am. J. Clin. Nutr. 77:912-918.
63. Gonthier, M.-P., Donovan, J. L., Texier, O., Felgines, C., Rémésy, C. & Scalbert, A. (2003) Metabolism of dietary procyanidins in rats. Free Radic. Biol. Med. 35:837-844.[Medline]
64. Setchell, K. D., Lawson, A. M., Conway, E., Taylor, N. F., Kirk, D. N., Cooley, G., Farrant, R. D., Wynn, S. & Axelson, M. (1981) The definitive identification of the lignans trans-2, 3-bis(3-hydroxybenzyl)-
-butyrolactone and 2, 3-bis(3-hydroxybenzyl)butane-1, 4-diol in human and animal urine. Biochem. J. 197:447-458.[Medline]
65. Ralph, J., Peng, J., Lu, F., Hatfield, R. D. & Helm, R. F. (1999) Are lignins optically active?. J. Agric. Food Chem. 47:2991-2996.[Medline]
66. Davin, L. B., Wang, H.-B., Crowell, A. L., Bedgar, D. L., Martin, D. M., Sarkanen, S. & Lewis, N. G. (1997) Stereoselective bimolecular phenoxy radical coupling by an auxiliary (dirigent) protein without an active center. Science (Washington, DC) 275:362-366.
67. Sicilia, T., Niemeyer, H. B., Honig, D. M. & Metzler, M. (2003) Identification and stereochemical characterization of lignans in flaxseed and pumpkin seeds. J. Agric. Food Chem. 51:1181-1188.[Medline]
68. Mazur, W. & Adlercreutz, H. (1998) Natural occurring oestrogens in food. Pure Appl. Chem. 70:1759-1776.
69. Boker, L. K., Van der Schouw, Y. T., De Kleijn, M. J., Jacques, P. F., Grobbee, D. E. & Peeters, P. H. (2002) Intake of dietary phytoestrogens by Dutch women. J. Nutr. 132:1319-1328.
70. de Kleijn, M. J., van der Schouw, Y. T., Wilson, P. W., Adlercreutz, H., Mazur, W., Grobbee, D. E. & Jacques, P. F. (2001) Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study. J. Nutr. 131:1826-1832.
71. Horn-Ross, P. L., Barnes, S., Kirk, M., Coward, L., Parsonnet, J. & Hiatt, R. A. (1997) Urinary phytoestrogen levels in young women from a multiethnic population. Cancer Epidemiol. Biomark. Prev. 6:339-345.[Abstract]
This article has been cited by other articles:
![]() |
M. R. O'Neil, G. P. Lardy, L. P. Reynolds, J. S. Caton, and K. A. Vonnahme Impacts of linseed meal and estradiol-17{beta} on mass, cellularity, angiogenic factors, and vascularity of the jejunum J Anim Sci, November 1, 2008; 86(11): 3014 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fardet, R. Llorach, A. Orsoni, J.-F. Martin, E. Pujos-Guillot, C. Lapierre, and A. Scalbert Metabolomics Provide New Insight on the Metabolism of Dietary Phytochemicals in Rats J. Nutr., July 1, 2008; 138(7): 1282 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. J. Milder, A. Kuijsten, I. C. W. Arts, E. J. M. Feskens, E. Kampman, P. C. H. Hollman, and P. Van 't Veer Relation between Plasma Enterodiol and Enterolactone and Dietary Intake of Lignans in a Dutch Endoscopy-Based Population J. Nutr., May 1, 2007; 137(5): 1266 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Touillaud, A. C. M. Thiebaut, A. Fournier, M. Niravong, M.-C. Boutron-Ruault, and F. Clavel-Chapelon Dietary Lignan Intake and Postmenopausal Breast Cancer Risk by Estrogen and Progesterone Receptor Status J Natl Cancer Inst, March 21, 2007; 99(6): 475 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. Milder, E. J. Feskens, I. C. Arts, H B. Bueno-de-Mesquita, P. C. Hollman, and D. Kromhout Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen Elderly Study. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 400 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Penalvo, S.-M. Heinonen, A.-M. Aura, and H. Adlercreutz Dietary Sesamin Is Converted to Enterolactone in Humans J. Nutr., May 1, 2005; 135(5): 1056 - 1062. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||